miércoles, 8 de mayo de 2019

At a big hearing on drug patents, Congress got distracted by small tweaks

At a big hearing on drug patents, Congress got distracted by small tweaks

The Readout

Damian Garde

More reads

  • They were supposed to talk about the patent system driving up drug prices. But most lawmakers got distracted by small tweaks. (STAT Plus)
  • The birth-tissue profiteers. (ProPublica)
  • A $2 million drug is about to hit the market. (Wall Street Journal)
  • 5 names to know at Google: the key players behind its health push. (STAT Plus)

No hay comentarios: